FHL is developing a number of innovative drugs to effectively treat common diseases among the aging population, including Parkinson’s disease, Alzheimer’s disease, and Rheumatoid Arthritis. These compounds range across small molecules derived from natural plants, repurposed drugs, and nasally-administered peptides.